Last reviewed · How we verify
Calcipotriol Betamethasone ointment
Calcipotriol Betamethasone ointment is a Small molecule drug developed by Xijing Hospital. It is currently FDA-approved.
At a glance
| Generic name | Calcipotriol Betamethasone ointment |
|---|---|
| Sponsor | Xijing Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products (PHASE2)
- LEO 90105 Ointment in Japanese Subjects With Psoriasis (PHASE3)
- Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris (PHASE2)
- The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris (PHASE1, PHASE2)
- Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris (PHASE3)
- Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris (PHASE3)
- LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis (PHASE3)
- LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcipotriol Betamethasone ointment CI brief — competitive landscape report
- Calcipotriol Betamethasone ointment updates RSS · CI watch RSS
- Xijing Hospital portfolio CI
Frequently asked questions about Calcipotriol Betamethasone ointment
What is Calcipotriol Betamethasone ointment?
Calcipotriol Betamethasone ointment is a Small molecule drug developed by Xijing Hospital.
Who makes Calcipotriol Betamethasone ointment?
Calcipotriol Betamethasone ointment is developed and marketed by Xijing Hospital (see full Xijing Hospital pipeline at /company/xijing-hospital).
What development phase is Calcipotriol Betamethasone ointment in?
Calcipotriol Betamethasone ointment is FDA-approved (marketed).